 |
Pfizer's Intellectual Property Rights Battles in China for Viagra
Pfizer Wins Viagra IPR Litigation - China In Transition?
In November 2006, the Bangbu Intermediate People's Court in the Anhui Province of the People's Republic of China (China) sentenced a Chinese man, Xi Yongli (Yongli), to eight years in prison for producing and selling counterfeits of Viagra, a drug for erectile dysfunction4 (ED), developed by the world's largest pharmaceutical company, Pfizer Inc. (Pfizer). In December 2006, a Beijing court upheld Pfizer's Chinese patent for Viagra and ordered two Chinese companies to stop making generic versions of the drug and to pay compensation of 600,000 yuan (US$ 76,726) for infringing on the registered trademark of Pfizer.5 |
|
Analysts saw these incidents as some of the successes achieved by Pfizer in its efforts to thwart the challenge posed by manufacturers of generic and fake drugs in a country that was known to offer weak intellectual property rights (IPR) protection.Many also saw these rulings as an indication of China's increasing commitment to provide adequate IPR protection in order to conform to the Trade Related Intellectual-Property Rights (TRIPS)6 agreements......
Pfizer's Intellectual Property Rights Battles in China for Viagra Cond..- Next Page>>
